IgA nephropathy, stem cell treatments among top nephrology news of 2023
Click Here to Manage Email Alerts
Healio has compiled a list of its most-read nephrology care news in 2023.
Readers were most interested in proteinuria and GFR results with a new IgA nephropathy drug, stem cell transplantation to protect donor kidneys and remarks from the former HHS Secretary on value-based care for end-stage kidney disease.
Trial results show decrease in proteinuria, stabilized GFR with IgA nephropathy drug
Results from a phase 2 trial of a new drug to treat IgA nephropathy showed a reduction in proteinuria and stabilization of eGFR vs. controls after 36 weeks, according to a presentation at the European Renal Association Congress. Read more.
Researchers successfully transplant stem cells to protect donor kidney
Transplantation of stem cells prior to the patient receiving the donor kidney prevented use of long-term anti-rejection drugs. Read more.
Former HHS Secretary says ‘no turning back’ on value-based care for ESKD
Healio interviewed Alex M. Azar II, who served as the HHS Secretary from 2018 to 2021. During that time, the agency launched Advancing American Kidney Health, an initiative that set new goals for patient treatment, created KidneyX to help companies develop new products, and launched new demonstrations and care models aimed at increasing home dialysis, transplantation and treating chronic kidney disease at earlier stages. Read more.
Women with health issues and CKD face complex challenges
Women who are pregnant and have preeclampsia worry nephrologists like Nityasree Srialluri, MD, MS, because without early detection, chronic kidney disease may not be far behind. Read more.
Collapse
Healio Coverage
Click Here to Manage Email Alerts